Location
United States, North America
Check Size
$100K - $5M
Investment Stage
Seed
Series A
Series B
Focus Areas
Health IT
Health & Hospital Services
Digital Health
BioTech
Consumer Health
Medical Devices
Impact
About Investor
Michael Powell is a Venture Partner at Omega Funds. His verified investing focus spans therapeutics/biotech, digital health, health IT, and medical devices at Seed–Series B, with a typical investment range of $100K–$5.0M. Previously he spent over two decades as Managing General Partner at Sofinnova Investments and earlier led drug delivery and CMC work at Genentech.
Previous investments
Aerium Therapeutics
2022
Checkmate Pharmaceuticals
85M |2020
27M |2017
20M |2015
Veridium
17M |2018
Similar Investors
AL
Abdul Ly
United States, North America
$1M - $4M
Seed
,Series A
,PS
Paul Straub
United States, North America
$100K - $2M
Pre Seed
,Seed
,SA
Shaun Abrahamson
United States, North America
$250K - $1M
Pre Seed
,Seed
,RF
Riley Florsheim
United States, North America
$100K - $5M
Pre Seed
,Seed
,SB
Steve Brownlie
United States, North America
$250K - $1.4M
Pre Seed
,Seed
,DG
Danielle Graham
Canada, North America
$100K - $300K
Pre Seed
,Seed
,Is this You?
Is this you? Have any edits?
Fill out our update request form and we'll update ASAP
Grow with the Right Investors
This profile is just one example. Our AI matches you with the investors who best fit your stage, industry, and vision.
Start Matching For Free